Topic: Reuters Group plc
SAN DIEGO (Reuters) - A single treatment with gene therapy, an experimental technique for fixing faulty genes, has been shown to boost output of a vital blood clotting factor, possibly offering a long-term solution for people with hemophilia B.Researchers said the same ...
SILVER SPRING, Maryland (Reuters) - A new Affymax Inc drug won expert backing to treat anemia in patients with chronic kidney disease who are on dialysis.A Food and Drug Administration advisory panel voted 15-1 on Wednesday, with one abstention, that peginesatide's benefits ...
CHICAGO (Reuters) - U.S. scientists have found a way to get mice with a form of sickle cell disease to make normal red blood cells, offering a potential new way to treat the blood disorder in people, they reported on Thursday.Adults with ...
CHICAGO (Reuters) - A second pivotal trial of ruxolitinib, developed by Incyte Corp and Novartis, met its goal of showing that the drug significantly reduces spleen size in myelofibrosis patients.The rare, but potentially deadly, blood cancer is characterized by bone marrow failure, ...
CHICAGO (Reuters) - A drug that eases symptoms of sickle cell disease in older children is safe and effective to use for babies with the blood disorder and should become the new standard of care, U.S. researchers said on Thursday.They said the ...
CHICAGO (Reuters) - Adults with sickle cell disease scored worse on memory function tests than healthy adults, suggesting the blood disorder may affect brain function, U.S. researchers said on Tuesday.The study is the first to look at brain function in adults with ...
WASHINGTON (Reuters) - U.S. regulators plan to ask outside experts to re-evaluate the use of Amgen Inc and Johnson & Johnson anemia drugs when given to patients with chronic kidney disease.Food and Drug Administration officials, in an article published in the New ...
NEW YORK (Reuters Health) - Exercise is good for you, but watch it: Drorit Merkel from the Chaim Sheba Medical Center, Tel-Hashomer and colleagues studied 153 males, all 18 years old, who were training to join an elite combat unit in the ...
NEW YORK (Reuters Health) - A new study shows that the annual cost of medical care in the US for people who suffer from sickle cell disease exceeds $1.1 billion.Sickle cell disease is an inherited blood disorder in which red blood cells ...
